ADDR 50 days' free access: Engineering Antigen-Presenting Cells for Immunotherapy of Autoimmunity.
By Jamal S. Lewis & coworkers UF BME
#DrugDelivery #AntigenPresentingCell #autoimmunity
authors.elsevier.com/a/1j5NY,3sXTmT…

ADDR 50 days' free access: Molecular probes for super-resolution imaging of drug dynamics.
By Weijiang He & coworkers Nanjing University
#imaging #resolution #probe
authors.elsevier.com/a/1j5D~,3sXTmT…

Together with Dr. Sarah Hedtrich we are co-editing a special issue Editors of Advanced Drug Delivery Reviews about dermal drug delivery. Here the first article that was published about #polymeric #microneedles . Link: sciencedirect.com/science/articl…

ADDR in press: Modulating the immune system towards a functional chronic wound healing: A biomaterials and Nanomedicine perspective.
By Rosa Maria Hernandez & coworkers UPV/EHU CRS Spanish Portuguese Local Chapter
#nanomedicine #biomateiral #WoundHealing
doi.org/10.1016/j.addr…

ADDR in press: Integrating microneedles and sensing strategies for diagnostic and monitoring applications: The state of the art.
By Davide Brambilla & coworkers Faculté de pharmacie
#microneedle #diagnosis #monitoring
doi.org/10.1016/j.addr…

Congratulations! Maria J. Vicent, the Editor-in-Chief of ADDR.

Check out this amazing review from Leaf's lab!

ADDR 50 days' free access: Editorial: Advanced strategies to bridge the gap between inflammation and tissue regeneration.
By Márcia T. Rodrigues & Manuela E. Gomes 3B's Research Group CRS Spanish Portuguese Local Chapter
#inflammation #TissueRegeneration
authors.elsevier.com/a/1j4p6,3sXTmT…

ADDR 50 days' free access: From cells to subcellular organelles: Next-generation cancer therapy based on peptide self-assembly.
By Huayang Liu & Huaimin Wang Westlake University
#SelfAssembly #peptide #SubcellularOrganelle
authors.elsevier.com/a/1j2m8,3sXTmT…

ADDR 50 days' free access: Pharmaceutical and Biotech Industry Perspectives on Optimizing Patient Experience and Treatment Adherence Through Subcutaneous Drug Delivery Design.
By Jennifer Stevenson & coworkers Amgen 🧪🔬🧬
#subcutaneous #injection #device
authors.elsevier.com/a/1j5I8,3sXTmT…

Check out our latest manuscript from the Jamal S. Lewis lab, “Engineering Antigen-Presenting Cells for Immunotherapy of Autoimmunity” published in Advanced Drug Delivery Reviews Editors of Advanced Drug Delivery Reviews! sciencedirect.com/science/articl…

ADDR Open Access: Nanoparticle-Neutrophils Interactions for Autoimmune Regulation.
By Omolola Eniola-Adefeso & coworkers Michigan Chemical Engineering
#nanoparticle #neutrophil #AutoimmuneDisease
doi.org/10.1016/j.addr…

ADDR 50 days' free access: Recent advances of Focused Ultrasound Induced Blood-Brain Barrier Opening for Clinical Applications of Neurodegenerative Diseases.
By Xinwu Cui & coworkers, Tongji Medical College
#BrainDelivery #ultrasound #BloodBrainBarrier
authors.elsevier.com/a/1j0Nt,3sXTmT…

ADDR in press: Novel strategies for modulating the gut microbiome for cancer therapy.
By James J. Moon & coworkers U-M Pharmacy
#formulation #microbiome #probiotics
doi.org/10.1016/j.addr…

ADDR 50 days' free access: [Editorial] Nanomedicine biointeractions during body trafficking.
By Wei Wu & co-editors Fudan University
#nanomedicine #BodyTrafficking
authors.elsevier.com/a/1j0Nt,3sXTmT…

ADDR 50 days' free access: Fusobacterium nucleatum Carcinogenesis and Drug Delivery Interventions.
By Leaf Huang & coworker UNC Pharmacy
#microbiota #immunotherapy
authors.elsevier.com/a/1i-tH,3sXTmT…

ADDR 50 days' free access: Delivery technologies for therapeutic targeting of fibronectin in autoimmunity and fibrosis applications.
By Karin Wang & coworkers Temple Bioengineering Karin Wang
#ExtracellularMatrix #autoimmunity
authors.elsevier.com/a/1i~z5_,Oflnf…

ADDR 50 days' free access: Advances in local drug delivery technologies for improved rheumatoid arthritis therapy.
By Feihu Wang & coworkers Shanghai Jiao Tong University
#LoalDelivery #arthritis authors.elsevier.com/a/1i~iY,3sXTmT…

ADDR Open Access: Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade.
By Ick Chan Kwon & coworkers ICKCHAN KWON KIST CRS Korea Chapter
#siRNA #GeneSilencing #CombinationTherapy
doi.org/10.1016/j.addr…

ADDR in press: Immunotherapies for locally aggressive cancers.
By Mark W. Grinstaff & coworkers Boston University Biomedical Engineering
#IntraoperativeDelivery #encapsulation #biomaterial
doi.org/10.1016/j.addr…